Today: 7 February 2026
Subscribe
Browse Category

Company Updates News 8 December 2025 - 12 December 2025

Transformers & Rectifiers (India) Stock (TARIL): Why the Share Price Jumped on Dec. 12, 2025 — Latest News, Forecasts, and Analyst Outlook

Transformers & Rectifiers (India) Stock (TARIL): Why the Share Price Jumped on Dec. 12, 2025 — Latest News, Forecasts, and Analyst Outlook

Dec. 12, 2025 — Transformers & Rectifiers (India) Ltd (NSE: TARIL, BSE: 532928) snapped a bruising downtrend on Friday, staging a sharp rebound with heavy volumes after sliding to a fresh 52-week low a session earlier. Moneycontrol The move wasn’t a quiet, “low-volume bounce.” It was the kind of trading day that makes even long-term investors sit up: the stock surged into the ₹260–₹268 zone intraday, while multiple market trackers flagged it among the most actively traded names in its segment by volume and/or value. Moneycontrol+2Markets Mojo+2 What’s driving the action, and what do current forecasts say next? Here’s a
12 December 2025
·····
City Developments Limited Stock News on Dec 12, 2025: DBS Lifts Target Price, Deals and What Analysts See Next

City Developments Limited Stock News on Dec 12, 2025: DBS Lifts Target Price, Deals and What Analysts See Next

City Developments Limited (CDL) stock is back in the spotlight on 12 December 2025, as fresh broker commentary and a string of portfolio moves reframe the investment debate around the Singapore developer: value unlocking versus leverage, and asset recycling versus new acquisitions. The Business Times+1 CDL shares were indicated higher during Friday’s session, with market watchers pointing to renewed optimism across Singapore property counters after DBS Research raised target prices for several developers—including CDL. SG Investors+2The Business Times+2 CDL share price today As of 14:38 on 12 December 2025, CDL was shown at S$7.34, up S$0.13 (+1.80%) on the day,
12 December 2025
·····
Wilmar International Limited Stock (SGX:F34) on Dec. 12, 2025: Latest News, Analyst Targets, and What to Watch Next

Wilmar International Limited Stock (SGX:F34) on Dec. 12, 2025: Latest News, Analyst Targets, and What to Watch Next

Wilmar International Limited (SGX:F34) is ending the week with investors balancing two competing narratives: a recovery in “underlying” operating momentum versus a stubborn legal and regulatory overhang spanning China and Indonesia. As of Dec. 12, 2025, Wilmar shares were trading around S$3.05 on the Singapore Exchange. SG Investors+1 Below is a detailed, up-to-date round-up of the most important Wilmar stock news, the latest forecasts and broker views in circulation, and the key catalysts that could matter next for the share price. Wilmar stock: what’s driving attention right now Wilmar is Asia’s large, integrated agribusiness platform—spanning edible oils, oilseed crushing, sugar,
12 December 2025
·····
Zip Co Ltd (ASX:ZIP) Share Price Today: Buyback Cancellations, New Performance Rights, US Dual-Listing Update, and Analyst Forecasts (12 Dec 2025)

Zip Co Ltd (ASX:ZIP) Share Price Today: Buyback Cancellations, New Performance Rights, US Dual-Listing Update, and Analyst Forecasts (12 Dec 2025)

Zip Co Ltd (ASX: ZIP) closed out the week with investors juggling two very different kinds of catalysts: the steady drip of capital-management filings (buyback updates, cancellations, and equity incentives) and the bigger narrative around US growth and a potential US dual listing. On Zip’s investor page, the company’s share price is shown at A$3.01 as at 12 December (16:20). ZipMarketScreener also shows Zip around A$3.01 on the day and highlights a notably wide gap between price and street targets: 10 analysts, a mean consensus “BUY,” and an average target price of A$5.095 versus a last close around A$3.00. MarketScreener
12 December 2025
·····
CSL Limited (ASX: CSL) Stock News Today: Buyback Update, Seqirus Uncertainty, and Analyst Forecasts for 2026

CSL Limited (ASX: CSL) Stock News Today: Buyback Update, Seqirus Uncertainty, and Analyst Forecasts for 2026

Published: December 12, 2025 CSL Limited stock (ASX: CSL) is back in the spotlight on December 12, 2025, with fresh disclosure showing the company’s on-market share buyback is still running at pace—while investors continue weighing a messy mix of catalysts: vaccine-market volatility, government scrutiny of Australia’s “sovereign manufacturing” deals, and a pipeline story that just landed in The New England Journal of Medicine. As of today, Investing.com shows CSL trading around A$182.42, versus a previous close of A$178.81, with an intraday range of A$179.45–A$182.72 and a 52-week range of A$168.00–A$290.32. Investing.com Below is a detailed wrap of the most relevant
12 December 2025
·····
AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Nears, Ligado FCC Filing Adds a Spectrum Catalyst, and Analysts Split on Price Targets

AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Nears, Ligado FCC Filing Adds a Spectrum Catalyst, and Analysts Split on Price Targets

Dec. 12, 2025 — AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight as investors weigh a very “space company” mix of catalysts: a highly anticipated next-generation satellite launch, fresh spectrum-related regulatory maneuvering tied to Ligado Networks, and a widening gap between where the stock trades and where many published analyst targets still sit. ASTS shares have been volatile—because of course they have. This is a pre-commercial, capital-intensive, launch-dependent business trying to turn ordinary smartphones into satellite-connected devices without special hardware. The upside story can be enormous, but the execution bar is… orbital. ASTS stock price check: where shares
12 December 2025
·····
Exxon Mobil (XOM) Stock Outlook After Hydrogen Pause and 2030 Plan Upgrade: Is There Still Upside for 2026?

Exxon Mobil (XOM) Stock Outlook After Hydrogen Pause and 2030 Plan Upgrade: Is There Still Upside for 2026?

Published: December 11, 2025 Exxon Mobil Corporation (NYSE: XOM) has packed a lot into the past few weeks. Since November 21, 2025, the oil major has: All of this has come as the stock trades near the high end of its 52‑week range and the oil market digests forecasts for softer crude prices in 2026. Below is a detailed, news‑style rundown of what’s changed for Exxon Mobil stock since November 21 and how analysts now see the risk–reward going into 2026. Key Takeaways Stock Performance Since November 21, 2025 On November 21, 2025, XOM closed at $117.08, on volume of
11 December 2025
·····
National Grid plc Stock: Sea Link Contracts, RIIO‑T3 Decision and Dividend Outlook as of 11 December 2025

National Grid plc Stock: Sea Link Contracts, RIIO‑T3 Decision and Dividend Outlook as of 11 December 2025

National Grid plc (LON: NG) heads into year‑end 2025 balancing three big themes that matter for shareholders: a massive UK grid build‑out, an active portfolio reshaping, and a still‑solid dividend stream – all against a backdrop of tight regulation and high leverage. As of the morning of 11 December 2025, the National Grid share price is trading a little above £11, modestly below recent highs but still up strongly for the year, while fresh news on new Sea Link contracts, Ofgem’s RIIO‑T3 settlement and a looming scrip‑dividend deadline is giving investors plenty to digest. MarketScreener+1 National Grid share price and
11 December 2025
··
Virgin Galactic Stock Plunges After Share Sale and Debt Deal: SPCE News, Forecasts and Analysis for December 10, 2025

Virgin Galactic Stock Plunges After Share Sale and Debt Deal: SPCE News, Forecasts and Analysis for December 10, 2025

Virgin Galactic Holdings, Inc. (NYSE: SPCE) is back under pressure this week as investors digest a new stock sale plan and a sweeping debt restructuring that together reshape the company’s balance sheet — and its risk profile. As of mid-session on December 10, 2025, SPCE is trading around $3.76, after closing at $3.81 on Tuesday. That close marked a ~16% single-day drop from $4.55, with trading volume surging to roughly 15–16 million shares — almost four times its recent average.StockInvest+1 The stock now sits more than 40% below its level at the start of 2025, and roughly 99% below its
10 December 2025
·····
Astera Labs Stock (ALAB): Price Target Lifted to $195 as AI Connectivity Story Deepens – December 9, 2025 Update

Astera Labs Stock (ALAB): Price Target Lifted to $195 as AI Connectivity Story Deepens – December 9, 2025 Update

Astera Labs, Inc. (NASDAQ: ALAB) remains in the spotlight as Wall Street revisits its valuation and AI investors digest a flood of new product and partnership news. On December 9, 2025, Astera’s stock is trading around $168 per share, down roughly 4% on the day, after a sharp rally that has seen the stock climb about 51% over the past six months and roughly 27% year‑to‑date. Yahoo Finance+1 At the same time, analysts are raising price targets, hedge funds are adjusting positions, and the company is doubling down on its role as a key connectivity provider for next‑generation AI data
9 December 2025
·····
Ares Management (ARES) Soars on S&P 500 Inclusion: Latest News, Analyst Forecasts and What’s Next for the Stock

Ares Management (ARES) Soars on S&P 500 Inclusion: Latest News, Analyst Forecasts and What’s Next for the Stock

Published: December 9, 2025 – All data as of intraday U.S. trading on this date. This article is for information only and is not investment advice. Ares Management Stock Today: S&P 500 News Sparks a Big Rally Ares Management Corporation (NYSE: ARES) is having a breakout session on December 9, 2025. The driver is clear: Ares is joining the S&P 500 index, replacing Kellanova (the company behind brands like Pringles and Pop‑Tarts), which is being acquired by Mars in a $36 billion deal. News Release Archive+1 This move instantly elevates Ares into the U.S. large‑cap mainstream, alongside alternative‑asset peers Blackstone,
9 December 2025
·····
Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech Corp. (NASDAQ: LEGN) shares are under heavy pressure on December 8, 2025, trading in the mid‑$20s and touching a new 52‑week low around $25.66 during the session. The slide comes despite strong clinical momentum for its flagship CAR‑T therapy CARVYKTI® and robust revenue growth, as investors react to valuation resets and ongoing concerns about profitability and cash flow. Investing.com+1 This article rounds up the key news and analysis on Legend Biotech stock from December 8, 2025 and the days immediately preceding it, and looks at what Wall Street expects next for LEGN. Disclaimer: This article is for information
8 December 2025
·····
1 … 25 26 27 28 29 … 34

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop